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Benzoimidazole compound has been synthesized and structurally characterized by single crystal X-ray diffraction 
studies, molecular docking and Hirshfeld surface analysis. The title compound C23 H14 N2 crystallizes in the Orthorhombic 
crystal system with the crystallographic space group of Pna21 with cell parameters a = 9.4472(5)Å, b=9.0556(5)Å, 
c=18.3755(11)Å, V=1572.03(15)Å3 and Z=4. The structure exhibits various intra and intermolecular interactions of the type 
N-H...N. Molecular docking studies of benzoimidazole compound have been executed with Cancer Osaka Thyroid kinease
target protein which shows high binding affinity. In addition to this, Hirshfeld surface computational analysis have been
carried out to analysis the hydrogen bond interaction. The major intermolecular contacts contributing to the Hirshfeld
surface are H...H, H...N and H...C, respectively.
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Benzoimidazoles moieties are an vital role of 
heterocyclic compounds contain nitrogen having great 
importance in the field of pharmaceutical industry, 
among heterocycles benzoimidazole occupied most 
significant place due to its diverse biological activities 
and the studies due to their broad range of 
applications (Gharib et al., 2014) such as angiotensin 
inhibitors (Trujillo et al., 2009), glucagon antagonist 
(Chang et al., 2001) and high cytotoxicity, which has 
preferable them as new drug in cancer therapy (King 
et al., 2006). The compound is a unique heterocyclic 
structure containing a benzene ring fused to an 
imidazole ring. The influence of the imidazoles can be 
attributed to its hydrogen bond donor-acceptor 
capability in addition to its high affinity for metals 
(e.g., Zn, Fe, Mg), which are found in many protein 
active sites. 
The benzophenone is an important organic 
compound used as a building block of many 
pharmaceutical compounds on its numerous 
biological activities such as anti-inflammatory, 
anticancer and so many activity (Winter et al., 1962), 
hence in the benzophenone compound is fused to 
benzoimidazoles to enhance more biological 
activities, subsequently we performed molecular 
docking for anti-cancer target with kinase protein is 
Cancer Osaka Thyroid Kinase protein and reported as 
better binding energy than previously reported ones, 
hence we report structural, molecular docking and 
Hirshfeld surfaces analysis studies of 2-(4,6-
dihydropyren-3-yl)-1H-benzodimidazole (Figure 1). 
Materials and Methods 
Synthesis of 2-(4,6-dihydropyren-3-yl)-1H-benzodimidazole 
Suitable proportions of o-phenylenediamine 
(1.08g; 10mmol) and 1-pyrenecarboxaldehyde (2.30g; 
10mmol) were mixed in 30 ml of acetonitrile 
thoroughly, followed by heating and stirring for about 
one hour. Resultant solution was cooled to room 
temperature forming a precipitate. The precipitate was 
collected by filtration, dried and ground using agate 
mortar in the presence of acetone (Scheme I). Finely 
powdered title compound was dissolved in mixed 
Figure 1 — Schematic diagram of benzodimidazole compound 




solvents of ethanol and chloroform and kept for 
crystallization by slow evaporation method.  
 
X-ray crystallography 
Single crystal x-ray diffraction intensity data have 
been collected for benzoimidazole compound on 
Bruker axs Kappa ApexII (Bruker, 2008) equipped 
with graphite mono-chromated MoKα (λ=0.7103 Å) 
radiation and CCD detector. The unit cell parameters 
have been determined from 36 frames measured (0.5° 
phiscan) from three different crystallographic zones 
and using the method of difference vectors. The 
intensity data collection, frames integrations (Lorentz 
and polarization) and decay correction have been 
done using SAINT-NT (version 7.06) (Bruker, 2008) 
software. Empirical absorption correction (multi-scan) 
has been performed using SADABS (Bruker, 2008) 
program. Crystal structures have been solved by 
direct methods using SHELXS-97 (Sheldrick, 2008). 
The phase sets with the best combined figure of 
merits reveal the positions of all non-hydrogen atoms 
in both the structures. The structures have been then 
refined by full-matrix least-squares procedures using 
SHELXL-97 (Sheldrick, 2008). 
 
Results and Discussion 
 
Crystallographic Studies 
Crystals of benzoimidazole suitable for single 
crystal X-ray analysis were grown via slow 
evaporation mixed solvents of ethanol and chloroform 
solution at room temperature. ORTEP plot of the 
diagram along with the atom-labelling scheme is given 
in Figure 2. X-ray crystallographic analysis revealed that 
benzoimidazole crystallizes in the monoclinic space 
group Pna21 and Z=4, full crystallographic data are 
presented in Table I. Selected bond lengths and bond 
angles of the benzoimidazole are given in Table II, 
Table III and Table IV, respectively. 
In benzimidazole moiety, C1-N2 bond of 1.390(5)° 
is formally treated as a double bond but N1-C6 = 
1.379(5) is shortened comparing to the single C-N 
(1.47Å) bond. The C1-N2 bond is longer than C6-N1. 
This shortening of distance is due to electron 
delocalization in the ring.  
The benzoimidazole ring [C1-C7/N1/N2] and 
pyrene ring [C8-C23] are planar conformation with 
maximum deviation of [C6=0.034(6) Å and C10=-
0.052(7)Å], respectively. The dihedral angle between 
the benzoimidazole ring and pyrene ring makes an 
angle of 40.44(17)° bridged by the bond C7-C8. The 
values of torsion angles N2-C7-C8-C9= 34.7(5)° and 







Figure 2 — ORTEP plot of the titled compound drawn at 50% of
probability level 
Table I — Crystal data and structure refinement details 
Parameter K21A 
Empirical formula C23 H14 N2 
Formula weight 318.36 
Temperature 293(2) K 
Wavelength 0.71073 Å 
Crystal system, space group Orthorhombic, P n a 21 
Unit cell dimensions a = 9.4472(5) Å  
 b = 9.0556(5) Å  
 c = 18.3755(11) Å  
Volume 1572.03(15) Å3 
Z, Calculated density 4, 1.345 Mg/m3 
Absorption coefficient 0.079 mm-1 
F(000) 664 
Crystal size 0.300 x 0.250 × 0.200 mm 
Theta range for data collection 2.217 to 24.987 º 
Limiting indices −10<=h<=11, 
−10<=k<=10, 
−21<=l<=21 
Reflections collected / unique 21841 / 2768 [Rint = 0.0502] 
Completeness to theta = 24.987 100.00% 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2768 / 1 / 231 
Goodness-of-fit on F^2 1.07 
Final R indices [I>2sigma(I)] R1 = 0.0370, wR2 = 0.0867 
R indices (all data) R1 = 0.0734, wR2 = 0.1119 
Absolute structure parameter −0.7(10) 
Extinction coefficient 0.007(2) 
Largest diff. peak and hole 0.150 and −0.152 e. Å-3 
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torsion angles take the same sign and are each 
reported to be 30°. 
Packing Features 
The crystal packing arrangement shows the 
formation of (C4) chain running along ab plane 
(Figure 2). N-H…N hydrogen-bonds are observed 
between the adjacent molecules to form hydrogen 
bond (Table IV, Figure 3). Another non-prominent 
intramolecular C-H…N hydrogen bond and vander 
waals force are also present.  
These hydrogen bonds add to the potential stability 
of the molecules within the crystal pack range 
(Figure 3), of the three-dimensional network 
structure. The crystal structure of benzoimidazole 
compound was studied using hirshfeld surface 
analysis study and confirmed using XRD analysis. 
Molecular Docking 
Protein preparation of COT kinase 
Protein kinases play a very vital role in the cell 
biology where it can modify the functioning of a protein 
in the cell. Protein phosphorylation is a process which 
can increase or decrease the enzyme activity to alter the 
Table IV — Geometric parameters of the intermolecular
interactions (Å,°) 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)
     
N1-H1...N2#1 0.90(4) 1.91(4) 2.796(4) 168(4) 
Symmetry transformations used to generate equivalent atoms: 
#1 x-1/2,-y+3/2,z 
Figure 3 — Packing of the molecules when viewed along ‘c’ axis 
Table II — Selected bond lengths (Å) and bond angles (°) 
Bond Length Bond Angle
C1-C2 1.389(5) C2-C1-N2 130.4(3)
C1-N2 1.390(5) C2-C1-C6 119.9(3)
C1-C6 1.390(5) N2-C1-C6 109.7(3) 
C2-C3 1.363(5) C3-C2-C1 117.5(4)
C3-C4 1.375(6) C2-C3-C4 122.2(4)
C4-C5 1.379(6) C3-C4-C5 121.7(4)
C5-C6 1.384(5) C4-C5-C6 116.1(4)
C6-N1 1.379(5) N1-C6-C5 132.3(3) 
C7-N2 1.316(5) N1-C6-C1 105.0(3) 
C7-N1 1.356(4) C5-C6-C1 122.6(4)
C7-C8 1.474(5) N2-C7-N1 112.1(3) 
C8-C9 1.388(5) N2-C7-C8 126.1(3) 
C8-C21 1.400(5) N1-C7-C8 121.4(3) 
C9-C10 1.374(6) C9-C8-C21 119.8(4) 
C10-C11 1.386(6) C9-C8-C7 117.1(3) 
C11-C22 1.419(5) C21-C8-C7 123.0(3) 
C11-C12 1.431(6) C10-C9-C8 121.3(4) 
C12-C13 1.332(6) C18-C23-C22 120.2(3) 
C21-C22 1.426(5) C14-C23-C22 120.0(4) 
C22-C23 1.422(5) C7-N1-C6 107.8(3) 
N1-H1 0.90(4) C7-N2-C1 105.4(3)
Table III — Selected torsion bond angles (°) 
Torsion Angle Torsion Angle
N2-C1-C2-C3 177.1(4) C7-C8-C21-C20 6.6(5) 
C6-C1-C2-C3 −0.8(6) C19-C20-C21-C8 −179.5(4)
C1-C2-C3-C4 0.3(7) C19-C20-C21-C22 1.1(5) 
C2-C3-C4-C5 0.1(7) C10-C11-C22-C23 177.8(3) 
C3-C4-C5-C6 −0.1(6) C12-C11-C22-C23 −2.1(5)
C4-C5-C6-N1 −176.2(4) C10-C11-C22-C21 −2.9(5)
C4-C5-C6-C1 −0.4(6) C12-C11-C22-C21 177.1(3)
C2-C1-C6-N1 177.7(4) C8-C21-C22-C11 0.1(5) 
N2-C1-C6-N1 −0.7(4) C20-C21-C22-C11 179.6(3)
C2-C1-C6-C5 0.9(6) C8-C21-C22-C23 179.3(3) 
N2-C1-C6-C5 −177.4(4) C20-C21-C22-C23 −1.2(5)
N2-C7-C8-C9 −137.0(4) C17-C18-C23-C14 −0.4(5)
N1-C7-C8-C9 34.7(5) C19-C18-C23-C14 179.7(3) 
N2-C7-C8-C21 39.5(6) C17-C18-C23-C22 179.9(3) 
N1-C7-C8-C21 −148.8(3) C19-C18-C23-C22 −0.1(5)
C12-C13-C14-C15 178.5(4) N2-C7-N1-C6 −0.5(4)
C12-C13-C14-C23 −2.6(6) C8-C7-N1-C6 −173.3(3)
C23-C14-C15-C16 −1.0(6) C5-C6-N1-C7 177.0(4)
C13-C14-C15-C16 177.9(4) C1-C6-N1-C7 0.7(4)
C14-C15-C16-C17 −0.2(7) N1-C7-N2-C1 0.1(4)
C15-C16-C17-C18 1.1(7) C8-C7-N2-C1 172.5(4)
C16-C17-C18-C23 −0.8(6) C2-C1-N2-C7 −177.8(4)
C16-C17-C18-C19 179.1(4) C6-C1-N2-C7 0.4(4) 




cellular processes like transcription and translation 
and play a major role in signal transduction pathways 
which can activate other protein to be functioned. 
[Roskoski, 2015; London, 2013]. 
One of the protein kinase is Cancer Osaka Thyroid 
Kinase which is a Mitogen Activated Protein Kinase 8 
(MAP3K8) (Figure 4). It involve to regulate various 
signaling pathways like cell survival, cell proliferation 
and cell death as well as various inflammatory 
pathways including ERK, JNK, p38, NFκB and plays 
an important role in the immune system also. 
 
Computational Methods 
The study reveals to demonstrate benzodimidazole 
derivative bind to Cancer Osaka Thyroid Kinase enzyme 
and to evaluate whether these molecules can be used as 
potential drug. The crystal structural information and 
target molecules were collected from the “Protein Data 
Bank” (PDB: 4Y83) (Gutmann et al., 2015).  
Imidazole ligand have many pharmacological 
properties and play an important role in biochemical 
processes (Lambardino and Wiseman, 1974). Three 
dimensional (3D) structures of the compounds were 
converted from CIF Format to Mol2 format by 
Marvin Sketch (Csizmadia, 1999).  
Vital hydrogen atoms in the protein molecule, 
Kollman united atom type charges, and solvation 
parameters were added with the aid of AutoDock 
tools (Morris et al., 1998). AutoDock Tools used to 
simulate the binding conformations between the 
compounds and protein. AutoDock with grid maps of 
(60×60×60) was applied to explore the binding sites 
of the target protein. The sites with lowest binding 
energies were further analyzed using AutoDock. 
The entire docking calculations were performed using 
Autodock docking module program. It performs flexible 
protein-ligand docking and searches for favorable 
interactions between one typically small ligand molecule 
and a typically larger protein molecule. Docking 
process, wherein protein preparation inhibited 
refinement is carried out with a maximum of 20 poses, 
wherein the side chains are optimized and refinement of 
residues takes place, if the ligand poses are within 5.0Å. 
The best docked structure was chosen by docking score 
and the number of amino acids matches (hydrogen 
bonds) with original drug complex.  
The docking energy and hydrogen bonding 
interactions of the benzoimidazole compound and co-
crystallized ligand are given in Table V. X-ray crystal 
structure of the Cancer Osaka Thyroid Kinase 
Receptor active site showing the key hydrogen  
contacts between inhibitor and enzyme is depicted in 
Figure 5. The co-crystallized ligand in the Cancer Osaka 
Thyroid Kinase Receptor active site showing the key 
hydrogen contacts between inhibitor and enzyme is 
shown in Figure 6. The surface diagram showing the 
title compound docked at the active site of Cancer Osaka  
Thyroid Kinase Receptor is depicted in Figure 7. 
 
 
Figure 4 — COT Kinase 3D diagram represented by using
Chimera visualization software 
Table V — Hydrogen bond interactions of Benzodimidazole with amino acids at the active site of Cancer Osaka Thyroid Kinase Receptor 
Compd Docking Score Hydrogen Bonding Interactions Hydrophobic 
Donor Acceptor Distance (Å)  





      
























Molecular docking analysis of Benzodimidazole 
indicated that hydrogen bond and hydrophobic are four 
major interactions (GLU220; HIS319; PRO154; 
TYR293 and THR290) incorporating the attachment of 
this ligand to Cancer Osaka Thyroid Kinase acceptor. 
The co-crystallized ligand also docked well and it shows 
better interactions with active residues. The results show 
that the title Benzodimidazole having better binding 
energy and the co-crystallized ligand have comparable 
interactions. It is indicated that Benzodimidazole has 
better ligand protein interactions and reflected that 
Benzodimidazole will have better antimicrobial 
character. The expected binding mode and binding 
orientation and electronic properties enabled 
optimization to Benzodimidazole as a more potent 
second-generation lead. 
 
Hirshfeld Surface Analysis 
Hirshfeld surface analysis (Spackman & Jayatilaka, 
2009) and 2D fingerprint plots (McKinnon et al., 2007) 
were performed using CrystalExplorer17 (Turner et al., 
2017), using standard surface resolution with the three-
dimensional surface resolution with the three-
dimensional dnorm surfaces plotted over a fixed colour 
scale of −0.6439 (red) to 1.2824 (blue) a.u. 
The 2D fingerprint plots depicts type of 
intermolecular contacts present in the molecule, and 
also relative contribution from each type of 
intermolecular interaction present in the molecule 
towards the packing of Hirshfeld surface area and it is 
illustrated in the Figure 8. Further 2D finger plots 
revealed major contribution to the packing of 
molecule are (i) H...H-(43.2%), (ii) C…H-(42.4), (iii) 
 
 
Figure 5 — The title compound in the Cancer Osaka Thyroid
Kinase Receptor active site showing key hydrogen contacts




Figure 6 — The co-crystallized ligand in the Cancer Osaka
Thyroid Kinase Receptor active site showing the key hydrogen





Figure 7 — Surface diagram showing the Benzodimidazole




Figure 8 — Hirshfeld surface analysis (a) dnorm, (b) curvedness,
(c) shape index and (d) fragment mapped for visualizing the inter
contacts of the title compound 




H...N-(6.8%) and (iv) C…C- (6.5%), is shown in the 
form of spikes, while that of minor contribution (v) 
C...N-(1.1%), (vi) N...N-(0.0%) also shown in 
Figure 9 indicates full. Figure 10 percentage of each 
pair of contact is illustrated in pie chart. 
 
Application 
The precise measurement of atomic positions, bond 
lengths, bond angles in a molecule and also the compound 
exhibited high binding affinity for anti-cancer activity. 
Conclusions 
The benzoimidazole compound is crystallized into 
orthorhombic crystal system with the space group of 
Pna21. The crystal structure is stabilized with an intra 
and intermolecular hydrogen bond type of N-H...N 
interaction. The molecular docking result showed that 
based on the benzoimidazole compound has good 
binding affinity with kinase target protein. Further 
hirshfeld surface analysis and 2D fingerprint plots 
revealed H...H, H...Cl and H...C are the major 
contribution in the crystal packing. 
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